FDA: Ecstasy ‘Breakthrough Therapy’ for PTSD

UNITED NEWS INTERNATIONAL (UNI) — Doctors may someday prescribe the party drug ecstasy in the United States to treat patients with PTSD.

According to the Washington Post, only two drugs are approved to treat PTSD and they are largely ineffective in treating veterans but the U.S. Food and Drug Administration called ecstasy, or MDMA, a “breakthrough therapy” to treat the condition.

The FDA says breakthrough therapies are those intended to treat serious or life-threatening conditions where evidence suggests the new therapy would be much better than existing treatments.

The Multidisciplinary Association for Psychedelic Studies, or MAPS, announced the the FDA’s designation Aug. 26.

Using MDMA causes an individual’s body to release chemicals like serotonin and dopamine, resulting in increased feelings of euphoria and empathy.

The FDA’s designation means it will work with MAPS to move MDMA through clinical trials quickly.